Meeting
2023 ASCO Annual Meeting
Laparoscopic versus open-surgery in FIGO stage II endometrioid endometrium cancers: Is there a prognostic effect?
Authors
Daniel Uwe Reimer
Innsbruck Medical University; Department of Obstetrics and Gynecology, Innsbruck, Austria
Daniel Uwe Reimer , Tanu Priya Bargujar , Katharina Leitner , Katharina Steger , Thomas Bartl , Christian Marth , Alain G Zeimet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5605)
DOI
10.1200/JCO.2023.41.16_suppl.5605
Abstract #
5605
Poster Bd #
300
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.
First Author: Jessica N. McAlpine
Poster
2022 ASCO Annual Meeting
The ENSURE trial for women with low-risk, early-stage endometrial cancer: A randomized controlled trial comparing the effect of a reduced (4 visits/3 yr) versus usual (8-11 visits/3 yr) follow-up schedule on patient satisfaction, health care use, and disease perception.
First Author: Lonneke van de Poll-Franse
Poster
2018 ASCO Annual Meeting
A 12 multigene NGS panel to characterize molecular biotypes in endometrial cancer.
First Author: Ignacio Romero
Poster
2014 ASCO Annual Meeting
Phase II study of XL184 (cabozantinib) in recurrent or metastatic endometrial cancer: A trial of the PMH, Chicago, and California Phase II Consortia.
First Author: Michelle Wilson